Navigation Links
Cancer Patient Denied Vital Drug

A 69-year-old cancer patient Brian Jago, from the UK has said that he is being denied of life saving drugs which are easily available in Wales and Scotland.// Jago has been diagnosed with a blood cancer called multiple myeloma in July 2003. He has undergone a stem cell transplant and a chemotherapy treatment which failed to check the disease.

The Southampton University Hospitals NHS Trust is reported to have cancelled the first course of the anti-cancer drug Velcade for him. A single course of the drug costs £15,000, and this appears to beyond the reach of Jago. The reason given by the hospital for denying him the course was that there was not sufficient evidence with regard to its effectiveness. The drug is also yet to receive its approval from the National Institute for Clinical Excellence. The real reason for this is believed to be a shortage of funds. Jago’s treatment was scheduled to start on 25 November 2005.
'"/>




Page: 1

Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2017)... ... June 26, 2017 , ... KICKICO , a protocol built on ... to solve many catastrophic issues within funding campaigns. KICKICO developers are testing the platform, ... crowdfunding - the raising of funds through the power of many - has been ...
(Date:6/25/2017)... (PRWEB) , ... June 25, 2017 , ... FCPX LUT ... into an old-fashioned vintage look. FCPX LUT Vintage Volume 2 contains 60 different color-grade ... grain for distorted looks, vignettes and blurs to single out subjects, plus much more. ...
(Date:6/25/2017)... , ... June 25, 2017 , ... Republicans in the ... and replace Obamacare, called the Better Care Reconciliation Act. It differs significantly from the ... will need to be reconciled in committee, or the House will have to take ...
(Date:6/25/2017)... (PRWEB) , ... June 25, 2017 , ... CareSet Labs ... in New Orleans. This is a new, greatly improved version of the Doctor ... Act (FOIA) requests by Fred Trotter and subsequently called the the “Doctor Referral Dataset” ...
(Date:6/25/2017)... ... 25, 2017 , ... June is Men’s Health Month and the focus is on ... men in the U.S. and the third most common cause of cancer related death today; ... in seven will be diagnosed with prostate cancer during his lifetime. Those at highest ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... , June 7, 2017 Endo International plc ... 7, 2017, the Hon. Joseph R. Goodwin , ... West Virginia , entered a case ... Pelvic Repair System Products Liability Litigation (the "MDL") that ... cases to provide expert disclosures on specific causation within ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
(Date:5/30/2017)... TEL AVIV, Israel , May 30, 2017 /PRNewswire/ ... clinical stage pharmaceutical Company specializing in the development ... management will present a company overview at three ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: